Godbole Manasi, Wani Kashmira, Zia Shereen, Dabak Vrushali
Hematology/Medical Oncology, Henry Ford Health System, Detroit, USA.
Internal Medicine, Henry Ford Health System, Detroit, USA.
Cureus. 2023 Jun 1;15(6):e39838. doi: 10.7759/cureus.39838. eCollection 2023 Jun.
Carcinoma en cuirasse is a rare cutaneous metastatic presentation of breast cancer with a poor prognosis. We report a female in her 70s with a prior history of left breast ductal carcinoma in situ status post-radiation and lumpectomy who presented with skin thickening of the left breast and a few solid masses in bilateral breasts. Biopsy showed invasive ductal carcinoma of the left breast (estrogen receptor [ER]/progesterone receptor positive [PR], human epidermal growth factor receptor-2 [HER2] negative) and ductal carcinoma in situ of the right breast (ER/PR positive). She underwent a right breast lumpectomy; however, the left breast mastectomy was aborted due to the worsening of her skin findings on preoperative examination. A skin biopsy revealed poorly differentiated invasive ductal carcinoma. She was diagnosed with stage 4 breast cancer, specifically carcinoma en cuirasse. Systemic treatment was initiated, followed by a left breast mastectomy. A surgical biopsy was HER2-positive, and therefore anti-HER2 therapy was given. She remains on maintenance therapy with an excellent response at present.Any unexplained skin findings in breast cancer patients should prompt consideration of carcinoma en cuirasse. With ongoing treatment advances, many newer therapy options are available for metastatic breast cancer. Based on our case, we think that patients with this disease can have better outcomes.
铠甲状癌是一种罕见的乳腺癌皮肤转移表现,预后较差。我们报告了一名70多岁的女性,既往有左乳腺导管原位癌病史,接受过放疗和肿块切除术,此次因左乳皮肤增厚及双侧乳房出现一些实性肿块前来就诊。活检显示左乳浸润性导管癌(雌激素受体[ER]/孕激素受体阳性[PR],人表皮生长因子受体2[HER2]阴性)及右乳导管原位癌(ER/PR阳性)。她接受了右乳肿块切除术;然而,由于术前检查发现皮肤情况恶化,左乳乳房切除术中止。皮肤活检显示为低分化浸润性导管癌。她被诊断为IV期乳腺癌,具体为铠甲状癌。开始进行全身治疗,随后进行了左乳乳房切除术。手术活检显示HER2阳性,因此给予了抗HER2治疗。她目前仍在接受维持治疗,反应良好。乳腺癌患者出现任何无法解释的皮肤表现时,都应考虑铠甲状癌。随着治疗的不断进展,转移性乳腺癌有了许多更新的治疗选择。基于我们的病例,我们认为这种疾病的患者可以有更好的预后。